We evaluate the usefulness of the target detection of 9–12 del BRCA1 as the first molecular diagnostic strategy in patients with Hereditary Breast and Ovarian Cancer (HBOC). Here, BRCA1 is linked to Hereditary breast and ovarian cancer syndrome.